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434 The Journal of Thoracic and Cardbjectives: We hypothesized that lung-volume reduction surgery for pulmonary
mphysema would improve body mass index, airflow obstruction, dyspnea, and
xercise capacity (BODE) index, a multidimensional predictor of survival in chronic
bstructive pulmonary disease. We also aimed to identify preoperative predictors of
mprovement in the BODE index.
ethods: In a prospective cohort study of patients undergoing lung-volume reduc-
ion surgery at our center, with the methodology of the National Emphysema
reatment Trial, we compared clinical characteristics before and 1 year after surgery
ith the Wilcoxon signed rank test. Changes in the BODE index were correlated
ith preoperative variables with the Spearman correlation coefficient.
esults: Twenty-three patients with predominantly upper-lobe pulmonary emphy-
ema underwent lung-volume reduction surgery (14 by video-assisted thoracoscopic
urgery, 9 by median sternotomy). There were no postoperative or follow-up deaths.
he BODE index improved from a median of 5 (interquartile range 4-5) before
urgery to 3 (interquartile range 2-4) 1 year after surgery (P  .0001). Improve-
ents were seen in the lung function and dyspnea components of the BODE index.
ower preoperative 6-minute walk distance and lower postwalk Borg fatigue scores
ere each associated with greater improvement in the BODE index after 1 year.
onclusion: Lung-volume reduction surgery for pulmonary emphysema improved
he BODE index in patients with predominantly upper-lobe disease. Lower preop-
rative 6-minute walk distance correlated with greater improvement in the BODE
ndex.
hronic obstructive pulmonary disease (COPD) is the fourth leading cause of
death in the United States, affecting 24 million Americans and accounting
for 119,000 deaths in the year 2000.1 Affected patients suffer from dyspnea,
unctional impairment, recurrent bronchopulmonary infections, and respiratory fail-
re. Although inhaled corticosteroids, long-acting bronchodilators, and pulmonary
ehabilitation improve some outcomes of this disease, only long-term oxygen
herapy and lung-volume reduction surgery (LVRS) have been shown to improve
urvival in selected patients with COPD.2-4
The National Emphysema Treatment Trial (NETT) showed that patients with
oth low postrehabilitation exercise capacity and predominantly upper-lobe pulmo-
ary emphysema had improved survival, exercise capacity, and quality of life with
VRS relative to those who did not undergo surgery.4 A total of 1218 study subjects
as used to detect these between-group differences.
iovascular Surgery ● June 2007
ei
f
f
N
a
s
s
(
R
(
s
a
s
i
r
r
p
o
B
e
y
v
M
W
L
2
i
t
(
s
a
p
s
r
C
c
n
m
r
r
t
I
e
d
s
r
m
i
t
S
C
D
r
w
c
c
c
v
(
f
R
T
p
6
c
p
m
(
1
p
p
m
c
c

c
p
a
s
r
1
5
(
i
t
r
Lederer et al General Thoracic Surgery
G
TSThe identification of a clinically meaningful surrogate
nd point that predicts survival for patients with COPD and
s affected by therapeutic interventions offers the potential
or designing appropriately powered clinical trials with a
raction of the time and resources required by trials such as
ETT. The body mass index, airflow obstruction, dyspnea,
nd exercise capacity (BODE) index is such a potential
urrogate end point in COPD.5 This multidimensional mea-
ure is composed of forced expiratory volume in 1 second
FEV1), the 6-minute walk distance, the modified Medical
esearch Council dyspnea score, and body mass index
Table 1). The BODE index is calculated by summing
cores assigned to each of its four components, resulting in
n overall score from 0 to 10; higher scores signify more
evere disease. In a multinational cohort study, each 1-point
ncrement in the BODE index conferred a 34% increased
isk of death from all causes and a 62% increased risk of
espiratory-related death.5 The BODE index was a better
redictor of mortality than was FEV1 alone.
In this study of patients undergoing LVRS after closure
f NETT, we hypothesized that LVRS would improve the
ODE index 1 year after surgery. We also explored preop-
rative predictors of improvement in the BODE index 1
ear after surgery. These results have been published pre-
iously in abstract form.6,7
aterials and Methods
e performed a prospective cohort study of patients undergoing
VRS at Columbia University Medical Center between January
004 and August 2005. The Columbia University Medical Center
nstitutional review board approved the study.
Patients were evaluated for LVRS by our multidisciplinary
eam with the methodology and selection criteria of NETT
Table 2).8 Postbronchodilator spirometry, plethysmography,
ingle-breath carbon monoxide diffusing capacity, room air
rterial blood gas analysis, 6-minute walk testing, and cardio-
ulmonary exercise testing were performed as previously de-
cribed.4 All exercise testing was performed after pulmonary
ehabilitation. The BODE index was calculated as described by
elli and colleauges5 (Table 1).
After pulmonary rehabilitation, patients who met all inclusion
riteria and no exclusion criteria underwent LVRS. Surgical tech-
ique was either bilateral video-assisted thoracoscopic surgery or
Abbreviations and Acronyms
BODE body mass index, airflow obstruction,
dyspnea, and exercise capacity
COPD chronic obstructive pulmonary disease
FEV1  forced expiratory volume in 1 second
IQR  interquartile range
LVRS  lung-volume reduction surgery
NETT  National Emphysema Treatment Trialedian sternotomy with the use of buttressed staple lines for v
The Journal of Thoracicesection. Patients underwent postoperative inpatient or outpatient
ehabilitation as clinically indicated. One year after surgery, pa-
ients returned for repeated testing.
We confirmed deaths with the Social Security Death Index.
ncomplete follow-up after LVRS, however, is likely due to wors-
ned health status or death.9 We therefore imputed missing 1-year
ata with the worst 1-year values in the entire cohort (worst rank
core imputation).10 For example, missing FEV1 values were
eplaced with the lowest FEV1 in the cohort (20%), whereas
issing BODE index values were replaced with the highest BODE
ndex in the cohort (6). This conservative approach was intended
o minimize any effect of LVRS on these end points.
tatistical Analysis
ontinuous variables were summarized by mean  SD.
iscrete ordinal variables were summarized by median,
ange, and interquartile range (IQR). Categorical variables
ere summarized by frequency and percentage. The Wil-
oxon signed rank test was used to compare changes in
ontinuous and ordinal discrete variables. The Spearman
orrelation coefficient was used to identify preoperative
ariables that were associated with the percentage reduction
improvement) in BODE index from baseline to 1-year
ollow-up.
esults
wenty-three patients underwent LVRS during the study
eriod (Table 3). The average age was 62  6 years, and
5% were female. More than 90% received inhaled corti-
osteroids and long-acting 2-agonists, 48% used tiotro-
ium, and 57% used long-term oxygen therapy. The median
odified Medical Research Council dyspnea score was 3
IQR 2-3). The average forced vital capacity was 59% 
3% predicted, and the average FEV1 was 25%  5%
redicted. All 23 patients had predominantly upper-lobe
ulmonary emphysema, as demonstrated by computed to-
ography. Seven (30%) had low postrehabilitation exercise
apacity as defined by NETT (maximal workload during
ardiopulmonary exercise testing 25 W for women or
40 Watts for men), and 16 (70%) had high exercise
apacity.
Surgical outcomes are presented in Table 4. Fourteen
atients (61%) underwent LVRS through bilateral video-
ssisted thoracoscopic surgery, and 9 (39%) by median
ternotomy. All patients were extubated in the operating
oom. The median intensive care unit stay was 2 days (range
-7 days), and the median hospital stay was 8 days (range
-18 days). Nine patients (39%) had a prolonged air leak
7 days), and there was 1 episode each of pneumonia,
nfected pleural space, arrhythmia, and transfusion of more
han 2 units of packed red blood cells. There were no deaths,
eintubations, or episodes of extended mechanical
entilation.
and Cardiovascular Surgery ● Volume 133, Number 6 1435
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FVC, Forced vital capacity; FEV1, forced expiratory volume in 1 second.
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1
G
TSTo date, 20 patients have completed 1-year follow-up
nd 3 have not. None of the 23 patients in the cohort
nderwent lung transplantation or died during follow-up.
here were clinically significant improvements in forced
ital capacity, FEV1, total lung capacity, single-breath car-
on monoxide diffusing capacity, and PaO2 on room air
Table 5). Exercise capacity also improved, as measured by
aximal workload during cardiopulmonary exercise testing
nd the 6-minute walk distance. Improved exercise capacity
ABLE 1. Components of body mass index, airflow obstruc
ariable
orced expiratory volume in 1 s (% predicted)
-min walk distance (m)
odified Medical Research Council dyspnea score*
ody mass index (kg/m2)
score from 0 to 3 (0–1 for body mass index) is assigned for each of the f
hich ranges from 0 to 10. *The modified Medical Research Council dyspn
oo breathless to leave the house or becomes breathless when dressing
asanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, a
ulmonary disease. N Engl J Med. 2004;350:1005-12. Copyright © 2004 Ma
ABLE 2. Inclusion and exclusion criteria
Inclusion criteria
History and physical examination consistent with pulmonary
emphysema
Body mass index 31.1 kg/m2 for men or 32.3 kg/m2 for
women
Prednisone dose 20 mg/d
Evidence of pulmonary emphysema on high-resolution
computed tomographic scan
Forced expiratory volume in 1 s 45% predicted (and 15%
for those 70 years old)
Total lung capacity 100% predicted, residual volume
150% predicted
PaCO2 60 mm Hg
PaO2 45 mm Hg breathing room air
Completion of pulmonary rehabilitation
After rehabilitation, 6-min walk distance 140 m
Exclusion criteria
Current use of tobacco
Previous lung-volume reduction surgery, lung transplantation,
or lobectomy
Clinically significant cardiac disease
Recurrent pulmonary infections
Pleural or interstitial lung disease
Systolic pulmonary artery pressure 45 mm Hg
Requirement for 6 L oxygen to maintain oxygen saturation
90% with exercise
Diffuse emphysema unsuitable for lung volume reduction
surgerytion, dyspnea, and exercise capacity (BODE) index
Points on BODE index
0 1 2 3
65 50–64 36–49 35
350 250–349 150–249 149
0-1 2 3 4
21 21
our BODE components. These scores are summed to generate the BODE index,
ea scale can range from 0 to 4, with a score of 4 indicating that the patient is
or undressing. (Adapted with permission from Celli BR, Cote CG, Marin JM,
irflow obstruction, dyspnea, and exercise capacity index in chronic obstructiveas accompanied by an improvement in peak minute ven-
436 The Journal of Thoracic and Cardiovascular Surgery ● JunABLE 3. Baseline characteristics
ariable
o. of patients 23
ge (y, mean  SD) 62  6
emale (No.) 15 (65%)
ody mass index (kg/m2, mean  SD) 26  4
redominantly upper-lobe emphysema (No.) 23 (100%)
esting pulmonary function
FVC (% predicted, mean  SD) 59%  13%
FEV1 (% predicted , mean  SD) 25%  5%
FEV1/FVC ratio (%, mean  SD) 35%  8%
Residual volume (% predicted, mean 
SD)
222%  45%
Diffusing capacity of carbon monoxide
(% predicted, mean  SD)
25%  8%
PaCO2 (mm Hg, mean  SD) 43  3
PaO2 on room air (mm Hg, mean  SD) 66  10
xercise capacity
Maximal workload (W, mean  SD)
Female (n  15) 34 10
Male (n8) 46  16
Low exercise capacity (No.) 7 (30%)
High exercise capacity (No.) 16 (70%)
Distance for 6-min walk (m, mean  SD) 417  73TABLE 4. Surgical outcomes
Variable
Hospital stay (d, median and range) 8 (5–18)
Intensive care unit stay (d, median and range) 2 (1–7)
Deaths (No.) 0
Complications (No.)
Prolonged air leak (7 days) 9 (39)
Pneumonia 1 (4)
Infected pleural space 1 (4)
Arrhythmia 1 (4)
Transfusion 2 units 1 (4)
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G
TSilation. Exertional dyspnea, but not exertional fatigue, im-
roved as well.
The BODE index improved from a median of 5 (IQR
-5) before surgery to a median of 3 (IQR 2-4) 1 year after
urgery (P  .0001). Of the four BODE index components,
nly the FEV1 and dyspnea scores changed during the study
eriod (Table 5).
Among the 20 patients with 1-year follow-up, preoper-
tive 6-minute walk distance (r  0.48, P  .03) and
ostwalk Borg fatigue score (r  0.65, P  .002) were
ach inversely associated with improvement in the BODE
ndex after 1 year.
iscussion
VRS improved the BODE index 1 year after surgery in
his post-NETT prospective study of patients with predom-
nantly upper-lobe pulmonary emphysema. Complications
ere minimal, and there were no deaths. Furthermore, lower
reoperative 6-minute walk distance and lower Borg fatigue
cores after walk testing were each associated with greater
mprovements in the BODE index after 1 year.
We found improvements in the BODE index in 17 of 23
atients after 1 year. Our results build on previous reports of
mprovements in the BODE index 3 months after LVRS and
fter pulmonary rehabilitation.11,12 Imfeld and coworkers11
ound that improvement in the BODE index 3 months after
VRS was associated with lower subsequent mortality.
ABLE 5. One year outcomes after lung-volume reduction
ariable
esting pulmonary function
Forced vital capacity (% predicted, mean  SD)
Forced expiratory volume in 1 s (% predicted, mean  SD)
Total lung capacity (% predicted, mean  SD)
Diffusing capacity of carbon monoxide (% predicted, mean  S
PaO2 on room air (mm Hg, mean  SD)
ardiopulmonary exercise testing
Maximal workload (W, mean  SD)
Maximum oxygen volume (mL/[min · kg], mean  SD)
Peak minute ventilation, body temperature and pressure, satura
est of 6-min walk
Walk distance (m, mean  SD)
Borg dyspnea score (median and interquartile range)
Borg fatigue score (median and interquartile range)
odified Medical Research Council dyspnea score (median and
ODE index scores (median and interquartile range)
Total BODE index
Forced expiratory volume in 1 s BODE score
Walk distance BODE score
Modified Medical Research Council dyspnea BODE score
Body mass index BODE score
values are for the comparison between baseline and 1-year values with
ith the worst rank score method (see Methods section). BODE, Body mlthough encouraging, however, these data do not establish s
The Journal of Thoraciche BODE index as a validated surrogate end point, because
o randomized trial has yet examined the BODE index.
uture studies are needed to examine this issue.
Although we found meaningful improvements in both
-minute walk distance and maximal workload during car-
iopulmonary exercise testing, we did not detect a change in
he 6-minute walk distance component of the BODE index.
ur high mean baseline 6-minute walk distance (417 m) is
ell above the threshold value of 350 m below which the
ODE index increases (Table 1). In fact, only 2 patients had
baseline 6-minute walk distance less than 350 m (each had
walk distance BODE score of 1), leaving little room for
mprovement.
Despite the insensitivity of the BODE index to improve-
ents in 6-minute walk distance in our study, we identified
ower preoperative 6-minute walk distance as a predictor of
he magnitude of improvement in the BODE index after 1
ear. This finding fits well with the current paradigm that
VRS confers the greatest benefit to those with the lowest
xercise capacity.4 In addition, those patients who reported
reater degrees of fatigue after 6-minute walk testing had
maller improvements in the BODE index. One interpreta-
ion of this finding is that LVRS benefits those whose
xercise is limited by dyspnea (suggesting limitation by
ung disease) rather than fatigue (which would suggest
imitation by deconditioning or cardiac disease).
After the closure of NETT, we continued to use NETT
ery
Baseline (n  23) At 1 y (n  23) P value
59 13 71  16 .0007
25 5 33  11 .0001
121 13 116  22 .04
25 8 31  9 .0001
66  10 70  9 .049
39 14 45  18 .02
12.0 2.5 12.6 3.6 .48
(L/min, mean  SD) 24 7 28  9 .01
417 73 455  71 .001
4 (4–5) 3 (1–4) .003
3 (1–4) 3 (0–4) .77
uartile range) 3 (2–3) 1 (0–2) .0001
5 (4–5) 3 (2–4) .0001
3 (3–3) 3 (2–3) .002
0 (0–0) 0 (0–0) .9999
2 (1–2) 0 (0–1) .0001
0 (0–0) 0 (0–1) .9999
ilcoxon signed rank test. Missing 1-year data for 3 subjects were imputed
dex, airflow obstruction, dyspnea, and exercise capacity.surg
D)
ted
interq
the Welection criteria and protocols in our institutional approach
and Cardiovascular Surgery ● Volume 133, Number 6 1437
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G
TSo LVRS. We credit our early success to the strict patient
election of NETT and the efforts of our multidisciplinary
VRS team, which is composed of thoracic surgeons, pul-
onologists, thoracic radiologists, a physiatrist, nurses, and
hysical and respiratory therapists.
There are several limitations to our study. First, our
ample size was small. We suggest that our predictors of
ODE improvement should be confirmed in a larger study.
econd, as emphasized previously, our subjects were highly
elected patients with emphysema at a single center, all with
redominantly upper-lobe disease. Our results should not be
pplied to those patients who do not meet NETT criteria or
o those with predominantly non–upper-lobe pulmonary
mphysema. Finally, with no mortality and a short fol-
ow-up period, we are unable to determine whether changes
n the BODE index after 1 year predict long-term prognosis.
onger follow-up of a larger cohort is needed.
In summary, we performed a prospective study of LVRS
ith no deaths with the inclusion criteria of NETT. LVRS
ignificantly improved the BODE index and its FEV1 and
yspnea components after 1 year. Lower preoperative
-minute walk distance and lower postwalk fatigue scores
redicted greater improvements in the BODE index. We
uggest future studies to confirm the BODE index as a
seful surrogate end point.
We thank the physical therapists, respiratory therapists, and
ther staff members of the Jo-Ann F. LeBuhn Center for Chest
isease and Respiratory Failure at Columbia University Medical
enter and New York Presbyterian Hospital.
438 The Journal of Thoracic and Cardiovascular Surgery ● Juneferences
1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic
obstructive pulmonary disease surveillance—United States, 1971-
2000. MMWR Surveill Summ. 2002;51:1-16.
2. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmo-
nale complicating chronic bronchitis and emphysema. Report of the
Medical Research Council Working Party. Lancet 1981;1:681-6.
3. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diag-
nosis and treatment of patients with COPD: a summary of the ATS/
ERS position paper [published erratum appears in Eur Respir J. 2006;
27:242]. Eur Respir J. 2004;23:932-46.
4. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A,
et al. A randomized trial comparing lung-volume-reduction surgery
with medical therapy for severe emphysema. N Engl J Med. 2003;348:
2059-73.
5. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M,
Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea,
and exercise capacity index in chronic obstructive pulmonary disease.
N Engl J Med. 2004;350:1005-12.
6. Lederer DJ, Jellen PA, Sonett JR, Austin JH, Brogan FL, Ginsburg
ME, et al. Lung volume reduction surgery improves the BODE index
[abstract]. Chest. 2005;128:179S.
7. Lederer DJ, Sonett JR, Jellen PA, Bartels MN, Yip CK, DiMango AM,
et al. Pre-operative exercise capacity predicts BODE index improve-
ment one year after lung volume reduction surgery [abstract]. Proc Am
Thorac Soc. 2006;3:A851.
8. Rationale and design of the National Emphysema Treatment Trial
(NETT): a prospective randomized trial of lung volume reduction
surgery. J Thorac Cardiovasc Surg. 1999;118:518-28.
9. Butler CW, Snyder M, Wood DE, Curtis JR, Albert RK, Benditt JO.
Underestimation of mortality following lung volume reduction surgery
resulting from incomplete follow-up. Chest. 2001;119:1056-60.
0. Lachin JM. Worst-rank score analysis with informatively missing
observations in clinical trials. Control Clin Trials. 1999;20:408-22.
1. Imfeld S, Bloch KE, Weder W, Russi EW. The BODE index after lung
volume reduction surgery correlates with survival. Chest. 2006;129:
873-8.
2. Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in
COPD. Eur Respir J. 2005;26:630-6.
e 2007
